FDA approves EsoFlip Dilation Catheter from Crospon

10/15/2013 | MedGadget.com

Irish firm Crospon received federal approval for its EsoFlip Dilation Catheter designed to dilate the gastroesophageal junction in individuals suffering from achalasia. The device transmits electrical data on lumen diameter during inflation and allows real-time viewing of the process.

View Full Article in:

MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC